Tag: S.Korea BioLogics delas

  • Samsung BioLogics eyes multiple supply deals

    Samsung BioLogics eyes multiple supply deals

    Samsung BioLogics is in discussions with over 15 global pharmaceutical firms on multiple supply deals, the company’s CEO said, as the biopharmaceutical unit of South Korea’s Samsung Group expands its presence in the global pharmaceutical market. “Samsung BioLogics already inked deals worth US$2.9 billion with six global pharmaceutical firms to supply a total of nine […]